# Holding vs. Continuing Incretin-based Therapies Before Upper Endoscopy

> **NCT06533527** · PHASE4 · COMPLETED · sponsor: **The Cleveland Clinic** · enrollment: 69 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2
- Obesity
- Gastroparesis

## Interventions

- **DRUG:** GLP-1 medication

## Key facts

- **NCT ID:** NCT06533527
- **Lead sponsor:** The Cleveland Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-07-31
- **Primary completion:** 2025-05-20
- **Final completion:** 2025-05-20
- **Target enrollment:** 69 (ACTUAL)
- **Last updated:** 2025-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06533527

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06533527, "Holding vs. Continuing Incretin-based Therapies Before Upper Endoscopy". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06533527. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*